Global and United States External Neuromodulation In-Depth Research Report 2017-2022
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in External Neuromodulation industry.
Major Companies
Medtronic, Inc. (U.S.)
Boston Scientific Corporation (U.S.)
St. Jude Medical, Inc. (U.S.)
Synapse Biomedical, Inc. (U.S.)
Nevro Corporation (U.S.)
Neurosigma, Inc. (U.S.)
Neuropace, Inc. (U.S.)
Neuronetics, Inc. (U.S.)
Cyberonics, Inc. (U.S.)
BioControl Medical (Israel)
Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
External Neuromodulation Market, byanscutaneous Electrical Nerve
External Neuromodulation Market, byanscranial Magnetic Stimulatio
External Neuromodulation Market, byspiratory Electrical Stimulati
External Neuromodulation Market, by Key Consumers
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in External Neuromodulation industry.
Major Companies
Medtronic, Inc. (U.S.)
Boston Scientific Corporation (U.S.)
St. Jude Medical, Inc. (U.S.)
Synapse Biomedical, Inc. (U.S.)
Nevro Corporation (U.S.)
Neurosigma, Inc. (U.S.)
Neuropace, Inc. (U.S.)
Neuronetics, Inc. (U.S.)
Cyberonics, Inc. (U.S.)
BioControl Medical (Israel)
Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
External Neuromodulation Market, byanscutaneous Electrical Nerve
External Neuromodulation Market, byanscranial Magnetic Stimulatio
External Neuromodulation Market, byspiratory Electrical Stimulati
External Neuromodulation Market, by Key Consumers
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others
CHAPTER ONE GLOBAL EXTERNAL NEUROMODULATION MARKET OVERVIEW
1.1 Global External Neuromodulation Market Sales Volume Revenue and Price 2012-2017
1.2 External Neuromodulation, by nscutaneous Electrical Nerve S 2012-2017
1.2.1 Global External Neuromodulation Sales Market Share by nscutaneous Electrical Nerve S 2012-2017
1.2.2 Global External Neuromodulation Revenue Market Share by nscutaneous Electrical Nerve S 2012-2017
1.2.3 Global External Neuromodulation Price by nscutaneous Electrical Nerve S 2012-2017
1.2.4
1.2.5
1.3 External Neuromodulation, by nscranial Magnetic Stimulation 2012-2017
1.3.1 Global External Neuromodulation Sales Market Share by nscranial Magnetic Stimulation 2012-2017
1.3.2 Global External Neuromodulation Revenue Market Share by nscranial Magnetic Stimulation 2012-2017
1.3.3 Global External Neuromodulation Price by nscranial Magnetic Stimulation 2012-2017
1.3.4
1.3.5
1.4 External Neuromodulation, by piratory Electrical Stimulatio 2012-2017
1.4.1 Global External Neuromodulation Sales Market Share by piratory Electrical Stimulatio 2012-2017
1.4.2 Global External Neuromodulation Revenue Market Share by piratory Electrical Stimulatio 2012-2017
1.4.3 Global External Neuromodulation Price by piratory Electrical Stimulatio 2012-2017
1.4.4
1.4.5
CHAPTER TWO UNITED STATES EXTERNAL NEUROMODULATION MARKET OVERVIEW
2.1 United States External Neuromodulation Market Sales Volume Revenue and Price 2012-2017
2.2 External Neuromodulation, by nscutaneous Electrical Nerve S 2012-2017
2.2.1 United States External Neuromodulation Sales Market Share by nscutaneous Electrical Nerve S 2012-2017
2.2.2 United States External Neuromodulation Revenue Market Share by nscutaneous Electrical Nerve S 2012-2017
2.2.3 United States External Neuromodulation Price by nscutaneous Electrical Nerve S 2012-2017
2.2.4
2.2.5
2.3 External Neuromodulation, by nscranial Magnetic Stimulation 2012-2017
2.3.1 United States External Neuromodulation Sales Market Share by nscranial Magnetic Stimulation 2012-2017
2.3.2 United States External Neuromodulation Revenue Market Share by nscranial Magnetic Stimulation 2012-2017
2.3.3 United States External Neuromodulation Price by nscranial Magnetic Stimulation 2012-2017
2.3.4
2.3.5
2.4 External Neuromodulation, by piratory Electrical Stimulatio 2012-2017
2.4.1 United States External Neuromodulation Sales Market Share by piratory Electrical Stimulatio 2012-2017
2.4.2 United States External Neuromodulation Revenue Market Share by piratory Electrical Stimulatio 2012-2017
2.4.3 United States External Neuromodulation Price by piratory Electrical Stimulatio 2012-2017
2.4.4
2.4.5
CHAPTER THREE EXTERNAL NEUROMODULATION BY REGIONS 2012-2017
3.1 Global External Neuromodulation Sales Market Share by Regions 2012-2017
3.2 Global External Neuromodulation Revenue Market Share by Regions 2012-2017
3.3 Global External Neuromodulation Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL EXTERNAL NEUROMODULATION BY COMPANIES 2012-2017
4.1 Global External Neuromodulation Sales Volume Market Share by Companies 2012-2017
4.2 Global External Neuromodulation Revenue Share by Companies 2012-2017
4.3 Global Top Companies External Neuromodulation Key Product Model and Market Performance
4.4 Global Top Companies External Neuromodulation Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES EXTERNAL NEUROMODULATION BY COMPANIES 2012-2017
5.1 United States External Neuromodulation Sales Volume Market Share by Companies 2012-2017
5.2 United States External Neuromodulation Revenue Share by Companies 2012-2017
5.3 United States Top Companies External Neuromodulation Key Product Model and Market Performance
5.4 United States Top Companies External Neuromodulation Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL EXTERNAL NEUROMODULATION BY CONSUMER 2012-2017
6.1 Global External Neuromodulation Sales Market Share by Consumer 2012-2017
6.2 Spinal Cord Stimulation
6.3 Deep Brain Stimulation
6.4 Sacral Nerve Stimulation
6.5 Others
6.6 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL EXTERNAL NEUROMODULATION BY CONSUMER 2012-2017
7.1 Global External Neuromodulation Sales Market Share by Consumer 2012-2017
7.2 Spinal Cord Stimulation
7.3 Deep Brain Stimulation
7.4 Sacral Nerve Stimulation
7.5 Others
7.6 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 Medtronic, Inc. (U.S.)
8.1.1 Medtronic, Inc. (U.S.) Company Details and Competitors
8.1.2 Medtronic, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.1.3 Medtronic, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.1.4 Medtronic, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.2 Boston Scientific Corporation (U.S.)
8.2.1 Boston Scientific Corporation (U.S.) Company Details and Competitors
8.2.2 Boston Scientific Corporation (U.S.) Key External Neuromodulation Models and Performance
8.2.3 Boston Scientific Corporation (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.2.4 Boston Scientific Corporation (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.3 St. Jude Medical, Inc. (U.S.)
8.3.1 St. Jude Medical, Inc. (U.S.) Company Details and Competitors
8.3.2 St. Jude Medical, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.3.3 St. Jude Medical, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.3.4 St. Jude Medical, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.4 Synapse Biomedical, Inc. (U.S.)
8.4.1 Synapse Biomedical, Inc. (U.S.) Company Details and Competitors
8.4.2 Synapse Biomedical, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.4.3 Synapse Biomedical, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.4.4 Synapse Biomedical, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.5 Nevro Corporation (U.S.)
8.5.1 Nevro Corporation (U.S.) Company Details and Competitors
8.5.2 Nevro Corporation (U.S.) Key External Neuromodulation Models and Performance
8.5.3 Nevro Corporation (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.5.4 Nevro Corporation (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.6 Neurosigma, Inc. (U.S.)
8.6.1 Neurosigma, Inc. (U.S.) Company Details and Competitors
8.6.2 Neurosigma, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.6.3 Neurosigma, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.6.4 Neurosigma, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.7 Neuropace, Inc. (U.S.)
8.7.1 Neuropace, Inc. (U.S.) Company Details and Competitors
8.7.2 Neuropace, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.7.3 Neuropace, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.7.4 Neuropace, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.8 Neuronetics, Inc. (U.S.)
8.8.1 Neuronetics, Inc. (U.S.) Company Details and Competitors
8.8.2 Neuronetics, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.8.3 Neuronetics, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.8.4 Neuronetics, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.9 Cyberonics, Inc. (U.S.)
8.9.1 Cyberonics, Inc. (U.S.) Company Details and Competitors
8.9.2 Cyberonics, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.9.3 Cyberonics, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.9.4 Cyberonics, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.10 BioControl Medical (Israel)
8.10.1 BioControl Medical (Israel) Company Details and Competitors
8.10.2 BioControl Medical (Israel) Key External Neuromodulation Models and Performance
8.10.3 BioControl Medical (Israel) External Neuromodulation Business SWOT Analysis and Forecast
8.10.4 BioControl Medical (Israel) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 External Neuromodulation Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 External Neuromodulation Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL EXTERNAL NEUROMODULATION MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global External Neuromodulation Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global External Neuromodulation Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global External Neuromodulation Sales (K Units) Forecast by Application (2017-2022)
10.4 Global External Neuromodulation Sales (K Units) Forecast by nscutaneous Electrical Nerve S (2017-2022)
10.5 Global External Neuromodulation Sales (K Units) Forecast by nscranial Magnetic Stimulation (2017-2022)
10.6 Global External Neuromodulation Sales (K Units) Forecast by piratory Electrical Stimulatio (2017-2022)
CHAPTER ELEVEN UNITED STATES EXTERNAL NEUROMODULATION MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States External Neuromodulation Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States External Neuromodulation Sales (K Units) Forecast by Regions (2017-2022)
11.3 United States External Neuromodulation Sales (K Units) Forecast by Application (2017-2022)
11.4 United States External Neuromodulation Sales (K Units) Forecast by nscutaneous Electrical Nerve S (2017-2022)
11.5 United States External Neuromodulation Sales (K Units) Forecast by nscranial Magnetic Stimulation (2017-2022)
11.6 United States External Neuromodulation Sales (K Units) Forecast by piratory Electrical Stimulatio (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Global External Neuromodulation Market Sales Volume Revenue and Price 2012-2017
1.2 External Neuromodulation, by nscutaneous Electrical Nerve S 2012-2017
1.2.1 Global External Neuromodulation Sales Market Share by nscutaneous Electrical Nerve S 2012-2017
1.2.2 Global External Neuromodulation Revenue Market Share by nscutaneous Electrical Nerve S 2012-2017
1.2.3 Global External Neuromodulation Price by nscutaneous Electrical Nerve S 2012-2017
1.2.4
1.2.5
1.3 External Neuromodulation, by nscranial Magnetic Stimulation 2012-2017
1.3.1 Global External Neuromodulation Sales Market Share by nscranial Magnetic Stimulation 2012-2017
1.3.2 Global External Neuromodulation Revenue Market Share by nscranial Magnetic Stimulation 2012-2017
1.3.3 Global External Neuromodulation Price by nscranial Magnetic Stimulation 2012-2017
1.3.4
1.3.5
1.4 External Neuromodulation, by piratory Electrical Stimulatio 2012-2017
1.4.1 Global External Neuromodulation Sales Market Share by piratory Electrical Stimulatio 2012-2017
1.4.2 Global External Neuromodulation Revenue Market Share by piratory Electrical Stimulatio 2012-2017
1.4.3 Global External Neuromodulation Price by piratory Electrical Stimulatio 2012-2017
1.4.4
1.4.5
CHAPTER TWO UNITED STATES EXTERNAL NEUROMODULATION MARKET OVERVIEW
2.1 United States External Neuromodulation Market Sales Volume Revenue and Price 2012-2017
2.2 External Neuromodulation, by nscutaneous Electrical Nerve S 2012-2017
2.2.1 United States External Neuromodulation Sales Market Share by nscutaneous Electrical Nerve S 2012-2017
2.2.2 United States External Neuromodulation Revenue Market Share by nscutaneous Electrical Nerve S 2012-2017
2.2.3 United States External Neuromodulation Price by nscutaneous Electrical Nerve S 2012-2017
2.2.4
2.2.5
2.3 External Neuromodulation, by nscranial Magnetic Stimulation 2012-2017
2.3.1 United States External Neuromodulation Sales Market Share by nscranial Magnetic Stimulation 2012-2017
2.3.2 United States External Neuromodulation Revenue Market Share by nscranial Magnetic Stimulation 2012-2017
2.3.3 United States External Neuromodulation Price by nscranial Magnetic Stimulation 2012-2017
2.3.4
2.3.5
2.4 External Neuromodulation, by piratory Electrical Stimulatio 2012-2017
2.4.1 United States External Neuromodulation Sales Market Share by piratory Electrical Stimulatio 2012-2017
2.4.2 United States External Neuromodulation Revenue Market Share by piratory Electrical Stimulatio 2012-2017
2.4.3 United States External Neuromodulation Price by piratory Electrical Stimulatio 2012-2017
2.4.4
2.4.5
CHAPTER THREE EXTERNAL NEUROMODULATION BY REGIONS 2012-2017
3.1 Global External Neuromodulation Sales Market Share by Regions 2012-2017
3.2 Global External Neuromodulation Revenue Market Share by Regions 2012-2017
3.3 Global External Neuromodulation Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL EXTERNAL NEUROMODULATION BY COMPANIES 2012-2017
4.1 Global External Neuromodulation Sales Volume Market Share by Companies 2012-2017
4.2 Global External Neuromodulation Revenue Share by Companies 2012-2017
4.3 Global Top Companies External Neuromodulation Key Product Model and Market Performance
4.4 Global Top Companies External Neuromodulation Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES EXTERNAL NEUROMODULATION BY COMPANIES 2012-2017
5.1 United States External Neuromodulation Sales Volume Market Share by Companies 2012-2017
5.2 United States External Neuromodulation Revenue Share by Companies 2012-2017
5.3 United States Top Companies External Neuromodulation Key Product Model and Market Performance
5.4 United States Top Companies External Neuromodulation Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL EXTERNAL NEUROMODULATION BY CONSUMER 2012-2017
6.1 Global External Neuromodulation Sales Market Share by Consumer 2012-2017
6.2 Spinal Cord Stimulation
6.3 Deep Brain Stimulation
6.4 Sacral Nerve Stimulation
6.5 Others
6.6 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL EXTERNAL NEUROMODULATION BY CONSUMER 2012-2017
7.1 Global External Neuromodulation Sales Market Share by Consumer 2012-2017
7.2 Spinal Cord Stimulation
7.3 Deep Brain Stimulation
7.4 Sacral Nerve Stimulation
7.5 Others
7.6 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 Medtronic, Inc. (U.S.)
8.1.1 Medtronic, Inc. (U.S.) Company Details and Competitors
8.1.2 Medtronic, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.1.3 Medtronic, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.1.4 Medtronic, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.2 Boston Scientific Corporation (U.S.)
8.2.1 Boston Scientific Corporation (U.S.) Company Details and Competitors
8.2.2 Boston Scientific Corporation (U.S.) Key External Neuromodulation Models and Performance
8.2.3 Boston Scientific Corporation (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.2.4 Boston Scientific Corporation (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.3 St. Jude Medical, Inc. (U.S.)
8.3.1 St. Jude Medical, Inc. (U.S.) Company Details and Competitors
8.3.2 St. Jude Medical, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.3.3 St. Jude Medical, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.3.4 St. Jude Medical, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.4 Synapse Biomedical, Inc. (U.S.)
8.4.1 Synapse Biomedical, Inc. (U.S.) Company Details and Competitors
8.4.2 Synapse Biomedical, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.4.3 Synapse Biomedical, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.4.4 Synapse Biomedical, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.5 Nevro Corporation (U.S.)
8.5.1 Nevro Corporation (U.S.) Company Details and Competitors
8.5.2 Nevro Corporation (U.S.) Key External Neuromodulation Models and Performance
8.5.3 Nevro Corporation (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.5.4 Nevro Corporation (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.6 Neurosigma, Inc. (U.S.)
8.6.1 Neurosigma, Inc. (U.S.) Company Details and Competitors
8.6.2 Neurosigma, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.6.3 Neurosigma, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.6.4 Neurosigma, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.7 Neuropace, Inc. (U.S.)
8.7.1 Neuropace, Inc. (U.S.) Company Details and Competitors
8.7.2 Neuropace, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.7.3 Neuropace, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.7.4 Neuropace, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.8 Neuronetics, Inc. (U.S.)
8.8.1 Neuronetics, Inc. (U.S.) Company Details and Competitors
8.8.2 Neuronetics, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.8.3 Neuronetics, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.8.4 Neuronetics, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.9 Cyberonics, Inc. (U.S.)
8.9.1 Cyberonics, Inc. (U.S.) Company Details and Competitors
8.9.2 Cyberonics, Inc. (U.S.) Key External Neuromodulation Models and Performance
8.9.3 Cyberonics, Inc. (U.S.) External Neuromodulation Business SWOT Analysis and Forecast
8.9.4 Cyberonics, Inc. (U.S.) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
8.10 BioControl Medical (Israel)
8.10.1 BioControl Medical (Israel) Company Details and Competitors
8.10.2 BioControl Medical (Israel) Key External Neuromodulation Models and Performance
8.10.3 BioControl Medical (Israel) External Neuromodulation Business SWOT Analysis and Forecast
8.10.4 BioControl Medical (Israel) External Neuromodulation Sales Volume Revenue Price Cost and Gross Margin
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 External Neuromodulation Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 External Neuromodulation Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL EXTERNAL NEUROMODULATION MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global External Neuromodulation Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global External Neuromodulation Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global External Neuromodulation Sales (K Units) Forecast by Application (2017-2022)
10.4 Global External Neuromodulation Sales (K Units) Forecast by nscutaneous Electrical Nerve S (2017-2022)
10.5 Global External Neuromodulation Sales (K Units) Forecast by nscranial Magnetic Stimulation (2017-2022)
10.6 Global External Neuromodulation Sales (K Units) Forecast by piratory Electrical Stimulatio (2017-2022)
CHAPTER ELEVEN UNITED STATES EXTERNAL NEUROMODULATION MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States External Neuromodulation Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States External Neuromodulation Sales (K Units) Forecast by Regions (2017-2022)
11.3 United States External Neuromodulation Sales (K Units) Forecast by Application (2017-2022)
11.4 United States External Neuromodulation Sales (K Units) Forecast by nscutaneous Electrical Nerve S (2017-2022)
11.5 United States External Neuromodulation Sales (K Units) Forecast by nscranial Magnetic Stimulation (2017-2022)
11.6 United States External Neuromodulation Sales (K Units) Forecast by piratory Electrical Stimulatio (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES AND FIGURES
Table Global External Neuromodulation Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global External Neuromodulation Revenue (Million USD) and Growth Rate (201
Table Global External Neuromodulation Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global External Neuromodulation Revenue (Million USD) and Growth Rate (201
